WebJul 1, 2021 · BERKELEY, Calif.-- ( BUSINESS WIRE )--Plexxikon, a member of the Daiichi Sankyo Group and a leader in structure-guided discovery and development of novel small molecule pharmaceuticals, today...
WebPlexxikon Announces Appointments of Dr. Chao Zhang to CEO and Marguerite Hutchinson, JD, to COO (picture below); Dr. Gideon Bollag to Step Down from CEO Role to Part-Time Position as Chief ...
DA:49PA:18MOZ Rank:22
Cancer drugmaker Plexxikon gets new life as Opna Bio
WebJul 1, 2021 · Plexxikon, a member of the Daiichi Sankyo Group and a leader in structure-guided discovery and development of novel small molecule pharmaceuticals, today …
WebChao Zhang. Dr. Zhang was named chief executive officer in July 2021, having previously served as a chief scientific officer and senior vice president of research. He joined … Occupation: CEO Works For: Plexxikon, Plexxikon
WebPlexxikon is an American drug discovery company based in South San Francisco, California. It was co-founded in 2001 by Joseph Schlessinger of Yale University, and Sung-Hou …
DA:77PA:79MOZ Rank:87
Entos lures former Plexxikon CEO to guide push toward the …
WebJul 8, 2022 · Kathy Wong. Editor. Nicole DeFeudis. Editor. Around the same time that Entos CEO Tom Miller realized it was time to bring on a CSO to guide the company’s cancer …
WebMay 31, 2013 · BERKELEY, Calif.-- (BUSINESS WIRE)-- Plexxikon Inc., a member of the Daiichi Sankyo Group, has announced the promotions of Gideon Bollag, Ph.D., to chief …
WebPlexxikon's Chief Executive Officer is Gideon E. Bollag. Other executives include Joseph Young, Senior Vice President, Finance; Jackie Walling, Consulting Chief Medical Officer …
